Genetic and Nongenetic Variation in Complex Traits
复杂性状的遗传和非遗传变异
基本信息
- 批准号:9923669
- 负责人:
- 金额:$ 33.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-05-03 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:BiologicalBiomedical ResearchCellsComplexDiseaseEukaryotaExperimental DesignsGeneticGenetic EpistasisGenetic VariationGenotypeGoalsGrowthHealthHeterogeneityHumanIndividualInfectionKnowledgeLeadMalignant NeoplasmsMapsMeasurementMethodsMicrobeMicroscopyModelingMolecularMutationNaturePathway interactionsPharmaceutical PreparationsPhenotypePopulationPredispositionResearchResistanceSaccharomyces cerevisiaeSaccharomycetalesShapesSourceStressSystemUncertaintyVariantWorkacute stressbasedisorder riskmicrobialnon-geneticpersonalized medicinepressureprogramspublic health relevancesingle cell analysistooltraittumor
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of this research program is to understand the mechanistic and evolutionary causes of variation in complex traits. The current focus is on mechanisms that appear to either suppress or promote variation. The primary experimental approach is to perform large-scale analyses of single-cell traits of the budding yeast, Saccharomyces cerevisiae. One line of work joins others in showing that cryptic genetic variation, kept suppressed until a perturbation reveals its phenotypic effects, is pervasive. This observation suggests that genetic interactions (epistasis) might be a major determinant of complex-trait variation. A second line of work joins others in suggesting that some clonal populations generate heterogeneity in order to hedge their bets against environmental uncertainty. The research program will follow these two lines of work. One set of projects aims to understand how epistasis contributes to natural variation in complex traits. Understanding the sources of variation in complex traits is a major goal in biomedical research because this knowledge impinges directly on the prospect of personalized medicine, for example the prediction of disease risk from an individual's genotype. If not taken into account, epistasis can confound such predictions. Epistasis is also important because it can constrain evolutionary adaptation to follow particular paths, making adaptation more predictable. This predictability could be valuable in the treatment of diseases that have a strong evolutionary component, such as microbial infections and cancer. Although epistasis has been well studied using lab- derived mutations, it has not been well studied in nature because most experimental designs have insufficient power to detect interacting loci. A key aim of this research program is to perform studies with dramatically increased power to detect interactions, for a large number of independent phenotypes, to gain a far richer view of the underlying causes of differences in complex traits. These studies will leverage recent progress in developing high-throughput, microscopy-based methods of quantifying many independent phenotypes, and they will create and use strains of S. cerevisiae that make searching for epistasis much more powerful. The other set of projects aims to understand the molecular mechanisms underlying a newly discovered bet-hedging phenomenon whereby clonal populations of S. cerevisiae contain fast-growing cells that are sensitive to acute stress and slow-growing cells that are tolerant of acute stress. Molecular mechanisms of this kind of adaptive heterogeneity are poorly understood, especially in eukaryotes, so the opportunity to study such a system in a model eukaryote with powerful genetic, molecular and cell-biological tools could lead to major advances. A candidate pathway for controlling the heterogeneity in growth and stress resistance will be studied. In addition, natural variation in growth-rate distributions between S. cerevisiae strains will be mapped, in an effort to understand how ecological pressures shape bet-hedging mechanisms. The two lines of work converge here because epistatic interactions appear to dominate the genetic basis of differences in growth-rate variance.
描述(由申请人提供):该研究计划的长期目标是了解复杂性状变异的机制和进化原因,目前的重点是抑制或促进变异的机制。对芽殖酵母(酿酒酵母)的单细胞性状进行大规模分析,其中一项工作与其他工作一起表明,神秘的遗传变异一直受到抑制,直到扰动揭示其表型。这一观察结果表明,遗传相互作用(上位性)可能是复杂性状变异的主要决定因素,第二项工作与其他研究一起表明,一些克隆群体会产生异质性,以对冲环境不确定性的赌注。该研究计划将遵循这两条工作线,旨在了解上位性如何促进复杂性状的自然变异,这是生物医学研究的一个主要目标,因为这种知识直接影响到复杂性状的自然变异。前景个性化医疗,例如根据个体基因型预测疾病风险,如果不考虑上位性,上位性也很重要,因为它可以限制进化适应遵循特定的路径,使适应更加可预测。尽管已经使用实验室衍生的突变对上位性进行了深入研究,但它在自然界中尚未得到充分研究,因为大多数实验设计没有足够的能力来治疗具有强大进化成分的疾病,例如微生物感染和癌症。检测相互作用的位点。该研究计划的一个关键目标是对大量独立表型的相互作用进行显着增强的检测能力,以获得对复杂性状差异的根本原因的更丰富的了解。这些研究将利用最近的进展。开发高通量、基于显微镜的方法来量化许多独立的表型,他们将创建和使用酿酒酵母菌株,使寻找上位性变得更加强大。另一组项目旨在了解新发现的分子机制。赌注对冲现象,即酿酒酵母克隆群体包含对急性应激敏感的快速生长的细胞和能够耐受急性应激的缓慢生长的细胞。人们对这种适应性异质性的分子机制知之甚少,特别是在真核生物中。因此,利用强大的遗传、分子和细胞生物学工具在模型真核生物中研究这样的系统的机会可能会导致控制生长和抗逆性异质性的候选途径的研究。此外,还将绘制酿酒酵母菌株之间生长率分布的自然变化图,以努力了解生态压力如何塑造赌注对冲机制。这两条工作线在此交汇,因为上位相互作用似乎主导了差异的遗传基础。增长率方差。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mark L Siegal其他文献
Mark L Siegal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mark L Siegal', 18)}}的其他基金
Genetic and Nongenetic Variation in Complex Traits
复杂性状的遗传和非遗传变异
- 批准号:
10552384 - 财政年份:2023
- 资助金额:
$ 33.3万 - 项目类别:
Photoactivatable cell sorting to link genetic variation with complex cellular phenotypes
可光激活的细胞分选将遗传变异与复杂的细胞表型联系起来
- 批准号:
10539111 - 财政年份:2022
- 资助金额:
$ 33.3万 - 项目类别:
Genetic and Nongenetic Variation in Complex Traits
复杂性状的遗传和非遗传变异
- 批准号:
9071727 - 财政年份:2016
- 资助金额:
$ 33.3万 - 项目类别:
Genetic and Nongenetic Variation in Complex Traits
复杂性状的遗传和非遗传变异
- 批准号:
10393771 - 财政年份:2016
- 资助金额:
$ 33.3万 - 项目类别:
Sources and consequences of phenotypic variation in complex regulatory networks
复杂调控网络中表型变异的来源和后果
- 批准号:
8437178 - 财政年份:2010
- 资助金额:
$ 33.3万 - 项目类别:
Sources and consequences of phenotypic variation in complex regulatory networks
复杂调控网络中表型变异的来源和后果
- 批准号:
8245747 - 财政年份:2010
- 资助金额:
$ 33.3万 - 项目类别:
Sources and consequences of phenotypic variation in complex regulatory networks
复杂调控网络中表型变异的来源和后果
- 批准号:
7887887 - 财政年份:2010
- 资助金额:
$ 33.3万 - 项目类别:
Sources and consequences of phenotypic variation in complex regulatory networks
复杂调控网络中表型变异的来源和后果
- 批准号:
8055405 - 财政年份:2010
- 资助金额:
$ 33.3万 - 项目类别:
相似国自然基金
生物医学跨本体术语相似度方法及其在B细胞非霍奇金淋巴瘤中的应用研究
- 批准号:62372276
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于RNA靶向新型AIE探针的细胞外囊泡荧光标记新方法的构建及其生物医学应用研究
- 批准号:82002245
- 批准年份:2020
- 资助金额:24 万元
- 项目类别:青年科学基金项目
真核基因定点编辑技术优化和基于高通量基因敲除文库搭建的功能性筛选平台在生物医学研究上的应用
- 批准号:31430025
- 批准年份:2014
- 资助金额:338.0 万元
- 项目类别:重点项目
新型DNAzyme荧光纳米探针的构建及其生物医学应用研究
- 批准号:21205068
- 批准年份:2012
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
生物医学中若干发展方程的研究
- 批准号:11171061
- 批准年份:2011
- 资助金额:45.0 万元
- 项目类别:面上项目
相似海外基金
Biologically-engineered Transcatheter Vein Valve: Design Optimization and Preclinical Testing
生物工程经导管静脉瓣膜:设计优化和临床前测试
- 批准号:
10594865 - 财政年份:2023
- 资助金额:
$ 33.3万 - 项目类别:
Regulation of Cellular Behavior in Response to Extracellular Cues
响应细胞外信号的细胞行为调节
- 批准号:
10557022 - 财政年份:2023
- 资助金额:
$ 33.3万 - 项目类别:
Data Resource and Administrative Coordination Center for the Scalable and Systematic Neurobiology of Psychiatric and Neurodevelopmental Disorder Risk Genes Consortium
精神科和神经发育障碍风险基因联盟的可扩展和系统神经生物学数据资源和行政协调中心
- 批准号:
10642251 - 财政年份:2023
- 资助金额:
$ 33.3万 - 项目类别:
Ultra-low-temperature (6 K) static NMR-DNP for metalloproteins, proteins in cells, and materials
用于金属蛋白、细胞中蛋白质和材料的超低温 (6 K) 静态 NMR-DNP
- 批准号:
10546201 - 财政年份:2023
- 资助金额:
$ 33.3万 - 项目类别:
BEASTS-Novel Biomimetic Liver Platform for Enabling ALD Researchers
BEASTS-为 ALD 研究人员提供支持的新型仿生肝脏平台
- 批准号:
10697452 - 财政年份:2023
- 资助金额:
$ 33.3万 - 项目类别: